Troy Ignelzi
2016 - scPharmaceuticals
In 2016, Troy Ignelzi earned a total compensation of $728.8K as Chief Financial Officer at scPharmaceuticals.
Compensation breakdown
| Option Awards | $401,942 |
|---|---|
| Salary | $255,758 |
| Other | $71,077 |
| Total | $728,777 |
Ignelzi received $401.9K in option awards, accounting for 55% of the total pay in 2016.
Ignelzi also received $255.8K in salary and $71.1K in other compensation.
Rankings
In 2016, Troy Ignelzi's compensation ranked 9,705th out of 14,075 executives tracked by ExecPay. In other words, Ignelzi earned more than 31.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,705 out of 14,075 | 31st |
Division Manufacturing | 3,757 out of 5,486 | 32nd |
Major group Chemicals And Allied Products | 1,308 out of 1,900 | 31st |
Industry group Drugs | 1,041 out of 1,543 | 33rd |
Industry Pharmaceutical Preparations | 817 out of 1,173 | 30th |
Source: SEC filing on April 30, 2018.
Ignelzi's colleagues
We found two more compensation records of executives who worked with Troy Ignelzi at scPharmaceuticals in 2016.
News
Karuna Therapeutics CEO Steven Paul's 2021 pay jumps 48% to $13M
April 27, 2022
Karuna Therapeutics CEO Steven Paul's 2020 pay slips 11% to $8.9M
April 27, 2021
Karuna Therapeutics CEO Steven Paul's 2019 pay jumps 932% to $10M
April 29, 2020
scPharmaceuticals CEO John Tucker's 2019 pay slips 17% to $1.2M
April 27, 2020
scPharmaceuticals CEO John Tucker's 2018 pay falls 25% to $1.5M
April 30, 2019